Global Insulin Pumps (External) Industry - NBC12.com - Richmond, VA News

Global Insulin Pumps (External) Industry

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker



 

 

LONDON, May 14, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Insulin Pumps (External) Industry

http://www.reportlinker.com/p092486/Global-Insulin-Pumps-External-Industry.html

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 13 companies including many key and niche players such as -

Animas Corp.
Debiotech S.A
F. Hoffmann-La Roche, Ltd.
Insulet Corp.
Medtronic




I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
Insulin Pumps: A Prelude II-1
The United States - The Largest Market II-1
Europe - A Market with Vast Potential II-2
Rising Incidence of Diabetes - The Driving Factor II-2
Table 1: Worldwide Prevalence of Diabetes Mellitus by Region:
2013 & 2035 P (includes corresponding Graph/Chart) II-4

2. COMPETITIVE ANALYSIS II-5
Insulin Pumps Market - Set for Interesting Road Ahead II-5
Table 2: Global External Insulin Pumps Market by Leading
Players (2013): Percentage Market Share Breakdown of Value
Sales for Medtronic, Insulet, Roche, J&J (Animas), and Others
(includes corresponding Graph/Chart) II-6

Table 3: Global Market for External Insulin Pumps by Leading
Players (2014E): Percentage Share Breakdown of Value Sales
for Medtronic, Insulet, Roche, J&J (Animas), Tandem and
Others (includes corresponding Graph/Chart) II-6
Comparison of Select Insulin Pumps by Manufacturer II-6
Competition Heats Up in the Patch Pumps Market II-7
Tough Ground for New Entrants II-8

3. MARKET TRENDS AND ISSUES II-9
The Rise of Smart Pumps - A Major Game Changer II-9
Artificial Pancreas System (APS) - The Future of Diabetes Care II-9
Type II Diabetes - A Market with Significant Potential II-10
The Risk of Diabetes in Aging Populace Presents Opportunities
for Insulin Pumps II-11
Table 4: Global Population Statistics for the 65+ Age Group
(Male & Female) for Major Countries/Regions: 2013E (includes
corresponding Graph/Chart) II-12
Alarming Rise in Obesity - A Business Case for Diabetes Care II-13
Table 5: Obesity Rates (%) in OECD Countries (includes
corresponding Graph/Chart) II-14

Table 6: Obese and Overweight & Obese Population in the World
(2013): Percentage Share Breakdown by Region for US, European
Union, and Rest of World (includes corresponding Graph/Chart) II-15
Diabetes in Developing Countries to Expand Opportunities II-15
Innovative Features Spruce Up the Market for Insulin Pumps II-16
Patch Pumps Gain Manufacturer Attention II-16
ICR: A Key Factor to Success II-16
Expiry of Warranty Provides New Opportunities to Insulin Pump
Makers II-17
Teenagers Outdo Adults in Controlling Diabetes II-17
Customer Satisfaction: Crucial to Stay Competitive II-17

4. CHALLENGES II-18
Implantable Insulin Pumps - A Potential Threat to External
Insulin Pumps II-18
Insulin Pump Training - Not Receiving Adequate Attention II-18
Complicated Insulin Pump Software Makes Pump Use Difficult for
the Aged II-18
Competition from Other Insulin Delivery Technologies Continues II-19
Undiagnosed Diabetes - A Key Challenge II-19
Lantus: A Threat to Insulin Pump Manufacturers II-19

5. DIABETES- INCIDENCE AND PREVALENCE II-20
Table 7: Global Diabetic Population by Region (2013 & 2035)
(includes corresponding Graph/Chart) II-21

Table 8: Top Ten Diabetic Countries (2013) by Number of
Individuals with Diabetes (includes corresponding Graph/Chart) II-22

Table 9: Top Ten Countries by Diabetic Population (2035)
(includes corresponding Graph/Chart) II-22
Diabetes - Assessing the Economic Burden II-22
Table 10: Diabetes Related Healthcare Expenditure by Region:
2013 (In US$ billion) (includes corresponding Graph/Chart) II-23
Diabetes Mellitus Cases Worldwide - A Demographic Analysis by
Geographic Region II-23
North America II-23
United States II-23
Canada II-23
Mexico II-24
Table 11: Prevalence of Diabetes Mellitus in North America
(2035 P): Breakdown by Country, Age Group, and Gender (In
Thousand People & %) (includes corresponding Graph/Chart) II-24
Europe II-24
Table 12: Prevalence of Diabetes Mellitus in Europe (2035P):
Breakdown by Country, Age Group, and Gender (In Thousand
People & %) II-25
Asia-Pacific II-26
Southeast Asian Region II-26
Western Pacific Region II-26
South & Central America II-26
Type-1 Diabetes II-26
Type-2 Diabetes II-26

6. DIABETES & INSULIN - AN ABSTRACT II-27
Diabetes - A Fatal Disease II-27
Risk Factors for Diabetes II-27
Types of Diabetes II-27
Long Term Complications of Diabetes II-28
Testing Sugar Levels: Easy and Accurate II-28
Insulin II-28
Pancreas: The Main Source of Insulin in Human Body II-28
Types of Insulin II-29
Types of Insulin & Onset of Action II-29
Goal of Insulin Therapy II-29
Insulin Delivery Systems II-29
Table 13: Global Insulin Delivery Devices Market by Leading
Players (2013): Percentage Market Share Breakdown for
Medtronic, Novo Nordisk, Sanofi and Others (includes
corresponding Graph/Chart) II-30
a. Syringes II-30
b. Insulin Pens II-31
c. Jet Injectors II-31
d. Tablets II-32
e. External Insulin Pumps II-32
f. Artificial Pancreas II-32
Insulin Delivery Technologies II-32

7. PRODUCT OVERVIEW II-33
Evolution of Insulin Pumps II-33
Insulin Pump - A Replica of Pancreas II-33
Advantages II-33
More Accurate and Consistent II-33
Enhances Blood Sugar Control in Pediatric Patients II-34
Adjusting Time Zones While Traveling II-34
Improves Quality of Life II-34
Patient Convenience II-34
Components of Insulin Pump II-35
How Does an Insulin Pump Work? II-35
Value-added Features of Modern Insulin Pumps II-35
Bolus Calculators II-35
Insulin On Board II-35
Customized Alarms II-36
Touch Bolus II-36
Interface to PCs II-36
Others II-36
Insulin Pump Delivery Rates II-36
Guidelines for Insulin Pump Usage II-36
Disadvantages/Risks Involved in the Usage of Insulin Pumps II-37
High Cost II-37
High Involvement II-38
Diabetic Ketoacidosis Risk II-38
Glucose Testing at Regular Intervals II-38
Regular Rotation of Infusion Set II-38
Carrying Back-up Kit II-38
Regular Refilling of Pump II-38

8. PRODUCT INNOVATIONS/INTRODUCTIONS II-39
Debiotech to Unveil Jewel Pump 2 II-39
Cellnovo Introduces Novel Insulin Pump System II-39
J&J Introduces Animas Vibe in Canada II-39
Tandem Introduces New Insulin Pump, t:slim, with a Touch Screen II-39

9. RECENT INDUSTRY ACTIVITY II-40
Roche and Novo Nordisk Team Up for Insulin Pump Cartridge II-40
Medtronic Secures FDA Approval for MiniMed 530G II-40
LifeScan Acquires Calibra Medical II-40
Mediq Takes Over Diabetes Specialty Center II-40
Indutrade to Acquire Rubin Medical II-40
Cellnovo Obtains CE Mark for Patch Pump II-40
Asante Secures 510 (K) Approval II-41
Medtronic and Bayer HealthCare Expand Collaboration to Cover
US Market II-41
Insulet Acquires Neighborhood Diabetes II-41
JDRF Enters into Partnership with Animas II-41
JDRF Collaborates with BD II-41
Insulet Inks Exclusive Distribution Agreement with Ypsomed II-41
Roche Takes Over Medingo II-41

10. FOCUS ON SELECT KEY PLAYERS II-42
Animas Corp. (USA) II-42
Debiotech S.A. (Switzerland) II-42
F. Hoffmann-La Roche, Ltd. (Switzerland) II-42
Insulet Corp. (USA) II-43
Medtronic (USA) II-43
Medtronic Diabetes (USA) II-44
Sooil Development Co. Ltd. (Korea) II-44
Tandem Diabetes Care Inc. (USA) II-45
Valeritas Inc. (US) II-45
Ypsomed Holding AG (Switzerland) II-45

11. GLOBAL MARKET PERSPECTIVE II-46
Table 14: World Recent Past, Current & Future Analysis for
Insulin Pumps (External) by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (exc. Japan), Latin America, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-46

Table 15: World Historic Review for Insulin Pumps (External)
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(exc. Japan), Latin America, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-47

Table 16: World 15-Year Perspective for Insulin Pumps
(External) by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific (exc.
Japan), Latin America, and Rest of World Markets for Years
2006, 2014 & 2020 (includes corresponding Graph/Chart) II-48


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Table 17: US Market Proliferation of Insulin Pumps in Type I
Diabetes Treatment (2010-2017P) (includes corresponding
Graph/Chart) III-1
Surging Diabetic Population Spurs Demand III-1
Table 18: US Diabetics Population (2010-2017): Percentage
Population with Diagnosed and Undiagnosed Diabetes
(includes corresponding Graph/Chart) III-2

Table 19: US Market for Diabetes Management (2014E &
2017P): Percentage Share Breakdown by Treatment Type
(includes corresponding Graph/Chart) III-3

Table 20: Diabetes Prevalence by Ethnicity (includes
corresponding Graph/Chart) III-3

Table 21: US Diabetes Prevalence (in 000's) for 2010-2017P
(includes corresponding Graph/Chart) III-4
Table 22: Diabetes Prevalence in the US by Type: 2013 (
includes corresponding Graph/Chart) III-4
Artificial Pancreas System (APS): The Future of Diabetes
Management III-4
Select Ongoing Clinical Studies on Artificial Pancreas
Technology III-5
Competitive Scenario III-5
Table 23: The US Insulin Pumps Market by Leading Players
(2013): Percentage Market Share Breakdown of Value Sales
for Medtronic, Animas (J&J), Insulet, and Others (includes
corresponding Graph/Chart) III-5

Table 24: Major Insulin Pump Systems Available in the US III-6
Reimbursements III-6
Regulatory Scenario III-7
FDA Announces a New Mandate for Manufacturing Companies III-7
Strategic Corporate Developments III-7
Key Players III-8
B.Market Analytics III-11
Table 25: The US Recent Past, Current & Future Analysis for
Insulin Pumps (External) Market Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-11

Table 26: The US Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-12

2. CANADA III-13
A.Market Analysis III-13
Product Launch III-13
B.Market Analytics III-13
Table 27: Canadian Recent Past, Current & Future Analysis
for Insulin Pumps (External) Market Analyzed with Annual
Sales Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-13

Table 28: Canadian Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-14

3. JAPAN III-15
Market Analysis III-15
Table 29: Japanese Recent Past, Current & Future Analysis
for Insulin Pumps (External) Market Analyzed with Annual
Sales Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-15

Table 30: Japanese Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-16

4. EUROPE III-17
A.Market Analysis III-17
Regional Scenario III-17
Diabetes Prevalence in Europe III-17
Table 31: Diabetes Mellitus in Europe (2013 & 2035P):
Percentage Breakdown of Prevalence in Population by Country
(includes corresponding Graph/Chart) III-18

Table 32: Percentage of Population with Diabetes and
Prevalence of Diabetes in the EU (2009-2015) (includes
corresponding Graph/Chart) III-19
Strategic Corporate Developments III-19
Select Key Players III-20
B.Market Analytics III-22
Table 33: European Recent Past, Current & Future Analysis
for Insulin Pumps (External) by Geographic Region - France,
Germany, Italy, UK, Spain, and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-22

Table 34: European Historic Review for Insulin Pumps
(External) by Geographic Region - France, Germany, Italy,
UK, Spain, and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Thousands for Years 2006
through 2012 (includes corresponding Graph/Chart) III-23

Table 35: European 15-Year Perspective for Insulin Pumps
(External) by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, and Rest
of Europe Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-24

4a. FRANCE III-25
Market Analysis III-25
Table 36: French Recent Past, Current & Future Analysis for
Insulin Pumps (External) Market Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-25

Table 37: French Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-26

4b. GERMANY III-27
Market Analysis III-27
Table 38: German Recent Past, Current & Future Analysis for
Insulin Pumps (External) Market Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-27

Table 39: German Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-28

4c. ITALY III-29
Market Analysis III-29
Table 40: Italian Recent Past, Current & Future Analysis for
Insulin Pumps (External) Market Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-29

Table 41: Italian Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-30

4d. THE UNITED KINGDOM III-31
A.Market Analysis III-31
INPUT (The Insulin Pump Therapy Group) III-31
NICE (National Institute of Clinical Excellence) III-31
Product Launch III-32
B.Market Analytics III-32
Table 42: The UK Recent Past, Current & Future Analysis for
Insulin Pumps (External) Market Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-32

Table 43: The UK Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-33


4e. SPAIN III-34
Market Analysis III-34
Table 44: Spanish Recent Past, Current & Future Analysis for
Insulin Pumps (External) Market Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-34

Table 45: Spanish Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-35

4f. REST OF EUROPE III-36
A.Market Analysis III-36
Russia III-36
Strategic Corporate Developments III-36
B.Market Analytics III-37
Table 46: Rest of European Recent Past, Current & Future
Analysis for Insulin Pumps (External) Market Analyzed with
Annual Sales Figures in US$ Thousands for Years 2013 through
2020 (includes corresponding Graph/Chart) III-37

Table 47: Rest of European Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-38

5. ASIA-PACIFIC III-39
A.Market Analysis III-39
Table 48: Diabetes Mellitus in Asia-Pacific (2013 & 2035 P):
Percentage Breakdown of Prevalence by Select Countries
(includes corresponding Graph/Chart) III-39
Review of Select Markets III-40
India III-40
Diabetes Scenario III-40
Insulin Pumps Gather Momentum III-40
Medtronic: The Undisputed Market Leader III-40
Diabetic Epidemic Spurs Indian Market III-41
China III-41
Overview III-41
Competition III-41
China: An Untapped Goldmine III-42
Key Player III-42
B.Market Analytics III-43
Table 49: Asia-Pacific Recent Past, Current & Future
Analysis for Insulin Pumps (External) Market Analyzed with
Annual Sales Figures in US$ Thousands for Years 2013 through
2020 (includes corresponding Graph/Chart) III-43

Table 50: Asia-Pacific Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-44

6. LATIN AMERICA III-45
A.Market Analysis III-45
Brazil III-45
B.Market Analytics III-46
Table 51: Latin American Recent Past, Current & Future
Analysis for Insulin Pumps (External) Market Analyzed with
Annual Sales Figures in US$ Thousands for Years 2013 through
2020 (includes corresponding Graph/Chart) III-46

Table 52: Latin American Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-47

7. REST OF WORLD III-48
A.Market Analysis III-48
UAE III-48
Demand for Insulin Pumps Grows Strongly in the UAE III-48
Product Launch III-48
B.Market Analytics III-49
Table 53: Rest of World Recent Past, Current & Future
Analysis for Insulin Pumps (External) Market Analyzed with
Annual Sales Figures in US$ Thousands for Years 2013 through
2020 (includes corresponding Graph/Chart) III-49

Table 54: Rest of World Historic Review for Insulin Pumps
(External) Market Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-50


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 13 (including Divisions/Subsidiaries - 16)

The United States (10)
Europe (4)
Asia-Pacific (Excluding Japan) (2)



To order this report: Global Insulin Pumps (External) Industry
http://www.reportlinker.com/p092486/Global-Insulin-Pumps-External-Industry.html



__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow